Insights

Innovative Crop Protection Enko is leveraging drug discovery approaches from pharma to develop novel insecticides and fungicides, signaling an opportunity to offer advanced, science-backed crop protection solutions to farmers facing resistance and emerging diseases.

AI Driven R&D With a history of funding rounds and partnerships focused on using artificial intelligence to accelerate discovery of agrochemicals, there is potential to position Enko’s tech-enabled pipeline to agribusinesses seeking faster time-to-market and differentiated products.

Strategic Collaboration Longstanding collaborations with Syngenta and backing from major investors indicate a strong ecosystem; sales conversations can target distributors, co-development partners, and farm input retailers seeking innovative solutions.

Global Growth Prospects Recent news highlights expansion initiatives and board-level appointments, suggesting opportunities to align with international growth plans, regional field teams, and compliance-ready formulations for diverse markets.

Sustainability Focus Enko emphasizes safe and sustainable crop solutions, appealing to sustainability-minded buyers and programs targeting reduced environmental impact, responsible stewardship, and potential eligibility for green funding or carbon/farm assurance programs.

Similar companies to Enko®

Enko® Tech Stack

Enko® uses 8 technology products and services including Amazon Web Services, Docker, PostgreSQL, and more. Explore Enko®'s tech stack below.

Media & News

Enko®'s Email Address Formats

Enko® uses at least 3 email formats:
Enko® Email FormatsExamplePercentage
First_Last@enko.agJohn_Doe@enko.ag
100%
First.Last@enkochem.comJohn.Doe@enkochem.com
98%
Fir.Last@enkochem.comJoh.Doe@enkochem.com
2%

Frequently Asked Questions

What is Enko®'s stock symbol?

Minus sign iconPlus sign icon
Enko® is a publicly traded company; the company's stock symbol is CNKS.L.

What is Enko®'s official website and social media links?

Minus sign iconPlus sign icon
Enko®'s official website is enko.ag and has social profiles on LinkedIn.

How much revenue does Enko® generate?

Minus sign iconPlus sign icon
As of July 2026, Enko®'s annual revenue is estimated to be $10M - $25M.

What is Enko®'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Enko®'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Enko® have currently?

Minus sign iconPlus sign icon
As of July 2026, Enko® has approximately 56 employees across 3 continents, including North America, Europe and South America. Key team members include Chief Executive Officer: A. K., Vice President Finance: S. P. S. and Company Owner: A. P. Explore Enko®'s employee directory with LeadIQ.

What industry does Enko® belong to?

Minus sign iconPlus sign icon
Enko® operates in the Biotechnology Research industry.

What technology does Enko® use?

Minus sign iconPlus sign icon
Enko®'s tech stack includes Amazon Web Services, Docker, PostgreSQL, NetSuite, scikit-learn, Office 365, Webflow and Microsoft Teams.

What is Enko®'s email format?

Minus sign iconPlus sign icon
Enko®'s email format typically follows the pattern of First_Last@enko.ag. Find more Enko® email formats with LeadIQ.

How much funding has Enko® raised to date?

Minus sign iconPlus sign icon
As of July 2026, Enko® has raised $135M in funding. The last funding round occurred on Jan 31, 2023.

When was Enko® founded?

Minus sign iconPlus sign icon
Enko® was founded in 2017.
Enko® logo

Enko®

Biotechnology ResearchConnecticut, United States51-200 Employees

Enko is a biotechnology research company that designs safe and sustainable solutions to protect crops from threats such as pests and diseases. By adapting drug discovery and development approaches from pharma to plants, it aims to accelerate the discovery and deployment of crop protection, offering an innovation model intended to meet evolving farming needs.

Section iconCompany Overview

Website
enko.ag
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
CNKS.L
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $135M

    Enko® has raised a total of $135M of funding over 5 rounds. Their latest funding round was raised on Jan 31, 2023 as a Series C.

  • $10M - $25M

    Enko®'s revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.